TB Research

<i>Mycobacterium tuberculosis</i> Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival

Banks DA, Ahlbrand SE, Hughitt VK, Shah S, Mayer-Barber KD, Vogel SN, El-Sayed NM, Briken V

Journal of immunology (Baltimore, Md. : 1950) · 2019-03

Abstract

The type I IFNs (IFN-α and -β) are important for host defense against viral infections. In contrast, their role in defense against nonviral pathogens is more ambiguous. In this article, we report that IFN-β signaling in murine bone marrow-derived macrophages has a cell-intrinsic protective capacity against Mycobacterium tuberculosis via the increased production of NO. The antimycobacterial effects of type I IFNs were mediated by direct signaling through the IFN-α/β-receptor (IFNAR), as Ab-mediated blocking of IFNAR1 prevented the production of NO. Furthermore, M. tuberculosis is able to inhibit IFNAR-mediated cell signaling and the subsequent transcription of 309 IFN-β-stimulated genes in a dose-dependent way. The molecular mechanism of inhibition by M. tuberculosis involves reduced phosphorylation of the IFNAR-associated protein kinases JAK1 and TYK2, leading to reduced phosphorylation of the downstream targets STAT1 and STAT2. Transwell experiments demonstrated that the M. tuberculosis -mediated inhibition of type I IFN signaling was restricted to infected cells. Overall, our study supports the novel concept that M. tuberculosis evolved to inhibit autocrine type I IFN signaling to evade host defense mechanisms.

MeSH terms

  • Animals
  • Mice, Knockout
  • Mice
  • Mycobacterium tuberculosis
  • Nitric Oxide
  • Interferon Type I
  • Autocrine Communication
  • Signal Transduction
  • Microbial Viability
  • Janus Kinase 1
  • TYK2 Kinase
  • Receptor, Interferon alpha-beta